GENOMICSCOLLABORATIVE Trademark

Computer programs for use in genomic research applications, namely, the analysis, data management, and data visualizations of biological sample collection, storing, and retrieval, as well as the identification of genes and proteins for pharmaceutical and diagnostic purposes

Prescription pharmaceuticals for use in the diagnosis and treatment of Cancers of the breast, cervix, colon, intestine, lung, lymph node, lymphoma, kidney, prostate, melanoma, ovary, stomach and uterus, inflammatory diseases including asthma, coronary artery disease, atherselerosis, congestive heart failure, rheumatoid arthritis, osteoarthritis, diseases of the central nervous system, chronic obstructive pulmonary disease, diabetes, lipid disorders, myocardial infarction, cerebrovascular accident, hypertension, leukemia, pneumonia, sepsis, and osteoporosis

Collecting, storing, analyzing, processing, cataloging, and dissemination of biological samples from global research and clinical sources for internal biomedical research for others; consulting services, namely, research, development, validation and testing services for others in the biomedical field and in the fields of genomics, diagnostics, and pharmaceuticals; computer services, namely, providing access to databases of life science information via global, national and local computer networks, creating and customizing databases for others in the field of life sciences, custom software design for others, and software maintenance and software support services, namely troubleshooting of computer software problems via telephone, email, in person and remote computer access; laboratory research services in the fields of computational chemistry, biology and genetics and, medical and diagnostic services for others, namely, diagnosing, preventing and predicting disease, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative programs, establishing disease treatments based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and computer tracking of patients health progress